A detailed history of State Board Of Administration Of Florida Retirement System transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 39,070 shares of RVMD stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,070
Previous 39,070 -0.0%
Holding current value
$1.69 Million
Previous $1.52 Million 16.75%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$30.14 - $40.68 $567,988 - $766,614
18,845 Added 93.18%
39,070 $1.52 Million
Q1 2024

May 08, 2024

SELL
$26.56 - $33.55 $500,523 - $632,249
-18,845 Reduced 48.23%
20,225 $651,000
Q4 2023

Feb 09, 2024

BUY
$18.35 - $34.12 $185,793 - $345,465
10,125 Added 34.98%
39,070 $1.12 Million
Q3 2023

Nov 08, 2023

BUY
$25.17 - $35.05 $3,775 - $5,257
150 Added 0.52%
28,945 $801,000
Q2 2023

Aug 11, 2023

BUY
$20.28 - $27.0 $173,799 - $231,390
8,570 Added 42.37%
28,795 $770,000
Q4 2022

Feb 07, 2023

BUY
$17.68 - $25.53 $6,541 - $9,446
370 Added 1.86%
20,225 $482,000
Q2 2022

Aug 05, 2022

BUY
$14.54 - $27.17 $19,192 - $35,864
1,320 Added 7.12%
19,855 $387,000
Q4 2021

Feb 08, 2022

BUY
$24.35 - $33.7 $3,116 - $4,313
128 Added 0.7%
18,535 $467,000
Q2 2021

Aug 10, 2021

BUY
$29.0 - $47.44 $155,005 - $253,566
5,345 Added 40.92%
18,407 $584,000
Q1 2021

May 10, 2021

BUY
$37.21 - $54.43 $21,209 - $31,025
570 Added 4.56%
13,062 $599,000
Q4 2020

Feb 08, 2021

BUY
$30.19 - $45.49 $377,133 - $568,261
12,492 New
12,492 $495,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.